Lawrence Russell Smith

Lawrence Russell Smith discloses dealings in Fresh Tracks Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 7 January 2014 to 15 March 2017, the count stands at 22 filings.

In open-market terms, that means 1 purchase worth €94k on one side and 15 sales worth €36k on the other. Netting one side against the other leaves €58k of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 6 share grants. Since January 2017: no purchases and 3 sales on the market.

The newest entry dates from 17 March 2017: an open-market sale of €1,905, in Fresh Tracks Therapeutics, Inc. The last purchase on record was published on 14 January 2014, which is 4,682 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.